Drug Warning: Mobic
Generic name: meloxicam (class of drugs known as NSAIDs)
Manufactured and marketed by: Abbott Laboratories
Purpose: Prescribed to patients suffering from the symptoms of rheumatoid arthritis and osteoarthritis, which may include swelling, inflammation, stiffness, and joint pain.
Side Effects Reported
- NSAIDs have been linked to liver damage.
- Patients taking NSAIDs, including Mobic, should be aware of the symptoms of liver damage which include yellow coloring of the skin or eyes, dark urine, fatigue, nausea, vomiting, loss of appetite, and flu like symptoms.
NSAIDs may also be linked to cardiovascular problems including heart attack and stroke. In addition, NSAIDs may be associated with an increased risk of hypertension, congestive heart failure, and edema. NSAIDs as a class are also linked to gastrointestinal problems including bleeding and ulceration.
Seeger Weiss is not currently pursuing lawsuits on this drug, but its drug warnings will remain on our radar.Free Case Evaluation
Seeger Weiss LLP is investigating allegations by the Justice Department that U.S. airlines may have unlawfully colluded to control the number of available seats on flights in order to drive up ticket [...]July 2, 2015 By: Seeger Weiss LLP read more
Results from a recent data mining study conducted at Houston Methodist and Stanford University, California, showed that patients using proton pump inhibitors face a significantly higher risk for suffering a heart attack [...]June 15, 2015 By: Seeger Weiss LLP read more
Experts at The University of Pittsburgh Medical Center and Ohio State University have called for more research into possible health risks of a potentially toxic chemical, gadolinium, remaining in brain tissue of [...]June 12, 2015 By: Seeger Weiss LLP read more